Serving leading biopharmaceutical companies globally:

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Olaratumab - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for olaratumab

Tradenames:	1
Patents:	8
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for olaratumab

Recent Clinical Trials for olaratumab

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Yonsei University	Phase 1/Phase 2
Apexigen, Inc.	Phase 2
Columbia University	Phase 2

See all olaratumab clinical trials

Patent Text Search: US Patents for olaratumab

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Eli Lilly And Co	LARTRUVO	olaratumab	INJECTABLE; INJECTION	761038	001	2019-07-10	Start Trial	biOasis Technologies, Inc. (Vancouver, British Columbia, unknown)	2031-08-05	RX	Orphan	search
Eli Lilly And Co	LARTRUVO	olaratumab	INJECTABLE; INJECTION	761038	001	2019-07-10	Start Trial	biOasis Technologies, Inc. (Richmond, CA)	2033-03-13	RX	Orphan	search
Eli Lilly And Co	LARTRUVO	olaratumab	INJECTABLE; INJECTION	761038	001	2019-07-10	Start Trial	SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR)	2033-05-29	RX	Orphan	search
Eli Lilly And Co	LARTRUVO	olaratumab	INJECTABLE; INJECTION	761038	001	2019-07-10	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for olaratumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Japan	2018110588	Start Trial
Japan	6357111	Start Trial
Japan	2016515121	Start Trial
China	108570468	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Baxter

Medtronic

McKesson

Colorcon

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.